Accuracy of CA 19-9 and Radiologic Imaging in Detecting Recurrence After Resection for Pancreatic Cancer
No abstract available.
Image: Pancreatic cancer cell.
Jahromi AH, Sangster G, Zibari G, Martin B, Chu Q, Takalkar A, Shi R, Amiri HS. Accuracy of multi-detector computed tomography, fluorodeoxyglucose positron emission tomography, and CA 19-9 levels in detecting recurrent pancreatic adenocarcinoma. JOP 2013; 24: 466-68.
Kim JK, Ha HK, Han DJ, Auh YH. CT analysis of postoperative tumor recurrence patterns in periampullary cancer Abdom Imaging 2003; 28: 384-91.
Ishigami K, Yoshimitsu K, Irie H, Tajima T, Asuyama Y, Hirakawa M, Kakihara D, Shioyama Y, Nishihara Y, Yamaguchi K, Honda H. significance of mesenteric lymphadenopathy after pancreaticoduodenectomy for periampullary carcinomas: evaluation with serial MDCT studies. Eur J radiol 2007; 61:491-98.
Sperti C, Pasquali C, Bissoli S, Chierichetti F, Liessi G, Pedrazzoli S. Tumor relapse after pancreatic cancer resection is detected earlier by 18-FDG PET than by CT. J Gastrointest Surg 2010; 14: 131-140.
Dibble EH, Karantanis D, Mercier G, Peller PJ, Kachnic LA, Subramaniam RM. PET/CT of cancer patients: part 1, pancreatic neoplasms. AJR Am J Roentgenol. 2012 Nov;199(5):952-67.
Asagi A, Ohta K, Nasu J, Tanada M, Nadano S, Nishimura R, Teramoto N, Yamamoto K, Inoue T, Iguchi H. Utility of contrast-enhanced FDG-PET/CT in the clinical management of pancreatic cancer. Impact on diagnosis, staging, evaluation of treatment response, and detection of recurrence. Pancreas 2013; 42: 11-19.
Copyright (c) 2014 Cosimo Sperti, Valentina Beltrame, Sergio Bissoli, Sergio Pedrazzoli
This work is licensed under a Creative Commons Attribution 4.0 International License.As a member of Publisher International Linking Association, PILA, iMedPub Group’s JOP follows the Creative Commons Attribution License and Scholars Open Access publishing policies. Journal of the Pancreas is the Council Contributor Member of Council of Science Editors (CSE) and following the CSE slogan Education, Ethics, and Evidence for Editors.